| keratinization | GO:0031424 | 9 | 0.691 | |
| intermediate filament cytoskeleton organization | GO:0045104 | 26 | 0.662 | |
| intermediate filament based process | GO:0045103 | 27 | 0.657 | |
| regulation of keratinocyte differentiation | GO:0045616 | 11 | 0.651 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.629 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.589 | |
| epidermis development | GO:0008544 | 187 | 0.586 | |
| hepatocyte apoptotic process | GO:0097284 | 11 | 0.511 | |
| regulation of epidermal cell differentiation | GO:0045604 | 21 | 0.486 | |
| skin development | GO:0043588 | 220 | 0.462 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.419 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.316 | |
| intermediate filament organization | GO:0045109 | 15 | 0.287 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.281 | |
| hair cycle | GO:0042633 | 90 | 0.280 | |
| molting cycle | GO:0042303 | 90 | 0.264 | |
| regulation of system process | GO:0044057 | 200 | 0.254 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.252 | |
| spermatogenesis | GO:0007283 | 284 | 0.252 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.250 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.247 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.233 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.231 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.228 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.216 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.216 | |
| camera type eye development | GO:0043010 | 266 | 0.215 | |
| positive regulation of dopamine secretion | GO:0033603 | 2 | 0.190 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.186 | |
| protein processing | GO:0016485 | 163 | 0.184 | |
| dendrite development | GO:0016358 | 115 | 0.180 | |
| striated muscle contraction | GO:0006941 | 45 | 0.176 | |
| skin morphogenesis | GO:0043589 | 38 | 0.169 | |
| water homeostasis | GO:0030104 | 27 | 0.168 | |
| tissue regeneration | GO:0042246 | 22 | 0.167 | |
| inflammatory response | GO:0006954 | 244 | 0.166 | |
| catecholamine secretion | GO:0050432 | 15 | 0.164 | |
| positive regulation of hair follicle development | GO:0051798 | 6 | 0.161 | |
| regulation of water loss via skin | GO:0033561 | 16 | 0.158 | |
| negative regulation of action potential | GO:0045759 | 1 | 0.157 | |
| tumor necrosis factor mediated signaling pathway | GO:0033209 | 13 | 0.151 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.149 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.149 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.145 | |
| sensory perception | GO:0007600 | 245 | 0.144 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.141 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.138 | |
| amine metabolic process | GO:0009308 | 45 | 0.137 | |
| wound healing | GO:0042060 | 157 | 0.133 | |
| epinephrine secretion | GO:0048242 | 1 | 0.131 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.128 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.126 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.120 | |
| regeneration | GO:0031099 | 38 | 0.118 | |
| hair follicle development | GO:0001942 | 85 | 0.118 | |
| synaptic transmission involved in micturition | GO:0060084 | 3 | 0.117 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.114 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.112 | |
| positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | GO:0001988 | 1 | 0.108 | |
| norepinephrine transport | GO:0015874 | 2 | 0.108 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.107 | |
| arachidonic acid metabolite production involved in inflammatory response | GO:0002538 | 2 | 0.103 | |
| epinephrine transport | GO:0048241 | 1 | 0.100 | |
| positive regulation of epidermis development | GO:0045684 | 13 | 0.096 | |
| protein maturation | GO:0051604 | 176 | 0.091 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.090 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.090 | |
| norepinephrine secretion | GO:0048243 | 2 | 0.087 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.086 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.086 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.085 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.084 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.083 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.083 | |
| generation of ovulation cycle rhythm | GO:0060112 | 1 | 0.082 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.081 | |
| gland development | GO:0048732 | 330 | 0.080 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.080 | |
| regulation of circadian sleep wake cycle rem sleep | GO:0042320 | 1 | 0.080 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.079 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.077 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.074 | |
| action potential | GO:0001508 | 78 | 0.073 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.072 | |
| muscle tissue development | GO:0060537 | 308 | 0.071 | |
| placenta development | GO:0001890 | 140 | 0.071 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.070 | |
| regulation of action potential | GO:0098900 | 4 | 0.070 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.069 | |
| cellular response to calcium ion | GO:0071277 | 14 | 0.068 | |
| renal vesicle induction | GO:0072034 | 3 | 0.067 | |
| response to tumor necrosis factor | GO:0034612 | 26 | 0.066 | |
| muscle system process | GO:0003012 | 141 | 0.065 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.065 | |
| kidney development | GO:0001822 | 213 | 0.064 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.063 | |
| transmembrane transport | GO:0055085 | 412 | 0.062 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.062 | |
| renal system process | GO:0003014 | 48 | 0.061 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.060 | |
| regulation of protein processing | GO:0070613 | 96 | 0.059 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.059 | |
| male gamete generation | GO:0048232 | 285 | 0.059 | |
| heart contraction | GO:0060047 | 93 | 0.058 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.057 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.057 | |
| lipoxygenase pathway | GO:0019372 | 5 | 0.056 | |
| organelle localization | GO:0051640 | 179 | 0.055 | |
| response to metal ion | GO:0010038 | 47 | 0.053 | |
| regulation of acetylcholine secretion neurotransmission | GO:0014056 | 2 | 0.052 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.052 | |
| cellular homeostasis | GO:0019725 | 240 | 0.052 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.052 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.050 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.050 | |
| cation transport | GO:0006812 | 399 | 0.050 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.049 | |
| cofactor transport | GO:0051181 | 4 | 0.049 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.049 | |
| retinal cone cell development | GO:0046549 | 8 | 0.048 | |
| circadian sleep wake cycle rem sleep | GO:0042747 | 1 | 0.048 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.046 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.046 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.046 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.046 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.045 | |
| response to denervation involved in regulation of muscle adaptation | GO:0014894 | 4 | 0.045 | |
| synaptic transmission | GO:0007268 | 329 | 0.044 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.042 | |
| cation homeostasis | GO:0055080 | 212 | 0.042 | |
| plasma membrane organization | GO:0007009 | 90 | 0.042 | |
| positive regulation of catecholamine secretion | GO:0033605 | 2 | 0.042 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.041 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.041 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.040 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.039 | |
| embryonic placenta development | GO:0001892 | 98 | 0.039 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.039 | |
| cellular response to tumor necrosis factor | GO:0071356 | 21 | 0.038 | |
| regulation of cell growth | GO:0001558 | 91 | 0.038 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.038 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.037 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.037 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.037 | |
| heart process | GO:0003015 | 94 | 0.037 | |
| hormone secretion | GO:0046879 | 128 | 0.037 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.036 | |
| regulation of interleukin 1 beta production | GO:0032651 | 25 | 0.036 | |
| muscle contraction | GO:0006936 | 101 | 0.036 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.036 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.036 | |
| response to radiation | GO:0009314 | 165 | 0.035 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.035 | |
| response to light stimulus | GO:0009416 | 135 | 0.035 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.035 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.035 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.034 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.034 | |
| mitral valve development | GO:0003174 | 4 | 0.034 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.033 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.033 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.033 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.033 | |
| response to iron ion | GO:0010039 | 4 | 0.033 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.033 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.033 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.033 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.033 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.032 | |
| response to amino acid | GO:0043200 | 37 | 0.032 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.032 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.032 | |
| lateral geniculate nucleus development | GO:0021771 | 1 | 0.032 | |
| organ growth | GO:0035265 | 117 | 0.032 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.032 | |
| positive regulation of hair cycle | GO:0042635 | 7 | 0.032 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.032 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.031 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.031 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.031 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.031 | |
| cellularization | GO:0007349 | 1 | 0.031 | |
| regulation of catecholamine secretion | GO:0050433 | 12 | 0.030 | |
| purinergic nucleotide receptor signaling pathway | GO:0035590 | 3 | 0.030 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.030 | |
| extracellular structure organization | GO:0043062 | 148 | 0.030 | |
| regulation of heart rate | GO:0002027 | 36 | 0.030 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.030 | |
| organelle assembly | GO:0070925 | 177 | 0.030 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.029 | |
| cell growth | GO:0016049 | 130 | 0.029 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.029 | |
| response to inorganic substance | GO:0010035 | 96 | 0.029 | |
| heart morphogenesis | GO:0003007 | 178 | 0.029 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.029 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.029 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.028 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.028 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.028 | |
| regulation of secretion | GO:0051046 | 274 | 0.028 | |
| monoamine transport | GO:0015844 | 33 | 0.028 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.028 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.028 | |
| chromatin organization | GO:0006325 | 206 | 0.027 | |
| response to acid chemical | GO:0001101 | 111 | 0.027 | |
| activation of transmembrane receptor protein tyrosine kinase activity | GO:0007171 | 3 | 0.027 | |
| membrane organization | GO:0061024 | 245 | 0.027 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.027 | |
| cellular response to salt stress | GO:0071472 | 1 | 0.027 | |
| developmental maturation | GO:0021700 | 193 | 0.027 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.027 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.026 | |
| epithelial cell development | GO:0002064 | 159 | 0.026 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.026 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.026 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.026 | |
| neuron migration | GO:0001764 | 122 | 0.026 | |
| acetylcholine transport | GO:0015870 | 2 | 0.026 | |
| regulation of hair cycle | GO:0042634 | 11 | 0.025 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.025 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.025 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.025 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.025 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.025 | |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.025 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.024 | |
| myoblast differentiation | GO:0045445 | 52 | 0.024 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.024 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.024 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.024 | |
| interleukin 6 production | GO:0032635 | 58 | 0.024 | |
| regulation of blood vessel size by renin angiotensin | GO:0002034 | 5 | 0.024 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.024 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.024 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.024 | |
| nephron epithelium development | GO:0072009 | 92 | 0.024 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.023 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.023 | |
| negative regulation of keratinocyte proliferation | GO:0010839 | 7 | 0.023 | |
| salivary gland morphogenesis | GO:0007435 | 33 | 0.023 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.023 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.023 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.023 | |
| axonogenesis | GO:0007409 | 274 | 0.023 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.023 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.023 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.023 | |
| regulation of translation | GO:0006417 | 71 | 0.023 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.023 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.023 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.023 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.022 | |
| translation | GO:0006412 | 93 | 0.022 | |
| cardiac chamber development | GO:0003205 | 108 | 0.022 | |
| regulation of hair follicle development | GO:0051797 | 9 | 0.022 | |
| regulation of ion transport | GO:0043269 | 215 | 0.022 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.022 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.022 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.022 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.022 | |
| fibrinolysis | GO:0042730 | 3 | 0.022 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.022 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.022 | |
| striated muscle cell development | GO:0055002 | 125 | 0.022 | |
| germ cell development | GO:0007281 | 185 | 0.022 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.022 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.021 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.021 | |
| tube lumen cavitation | GO:0060605 | 5 | 0.021 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.021 | |
| regulation of circadian sleep wake cycle non rem sleep | GO:0045188 | 1 | 0.021 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.021 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.021 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.021 | |
| defecation | GO:0030421 | 1 | 0.021 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.021 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.021 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.020 | |
| t cell activation | GO:0042110 | 289 | 0.020 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.020 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.020 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.020 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.020 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.020 | |
| lipid localization | GO:0010876 | 126 | 0.020 | |
| negative regulation of interleukin 1 beta production | GO:0032691 | 5 | 0.020 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.020 | |
| stem cell differentiation | GO:0048863 | 268 | 0.020 | |
| otic placode formation | GO:0043049 | 1 | 0.020 | |
| detection of external stimulus | GO:0009581 | 61 | 0.020 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.020 | |
| visual perception | GO:0007601 | 52 | 0.020 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.019 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.019 | |
| neuron death | GO:0070997 | 154 | 0.019 | |
| potassium ion transport | GO:0006813 | 52 | 0.019 | |
| regulation of protein transport | GO:0051223 | 163 | 0.019 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.019 | |
| regulation of tube size | GO:0035150 | 57 | 0.019 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.019 | |
| lipid catabolic process | GO:0016042 | 69 | 0.019 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.019 | |
| interleukin 1 production | GO:0032612 | 31 | 0.019 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.018 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.018 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.018 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.018 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.018 | |
| circadian sleep wake cycle non rem sleep | GO:0042748 | 2 | 0.018 | |
| dopamine secretion | GO:0014046 | 9 | 0.018 | |
| regulation of transcription from rna polymerase ii promoter involved in forebrain neuron fate commitment | GO:0021882 | 3 | 0.018 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.018 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.018 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.018 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.018 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.017 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.017 | |
| renal tubular secretion | GO:0097254 | 2 | 0.017 | |
| protein secretion | GO:0009306 | 111 | 0.017 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.017 | |
| limb development | GO:0060173 | 166 | 0.017 | |
| compound eye development | GO:0048749 | 1 | 0.017 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.017 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.017 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.017 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.017 | |
| oxidation reduction process | GO:0055114 | 342 | 0.017 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.017 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.017 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.017 | |
| microtubule based process | GO:0007017 | 236 | 0.017 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.017 | |
| cell maturation | GO:0048469 | 127 | 0.017 | |
| hepoxilin biosynthetic process | GO:0051122 | 1 | 0.017 | |
| positive regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014718 | 2 | 0.017 | |
| cardiac septum development | GO:0003279 | 59 | 0.017 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.016 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.016 | |
| urogenital system development | GO:0001655 | 261 | 0.016 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.016 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.016 | |
| syncytium formation | GO:0006949 | 43 | 0.016 | |
| lung development | GO:0030324 | 164 | 0.016 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.016 | |
| sensory perception of sound | GO:0007605 | 97 | 0.016 | |
| positive regulation of heart rate | GO:0010460 | 10 | 0.016 | |
| cell fate commitment | GO:0045165 | 210 | 0.016 | |
| rhythmic process | GO:0048511 | 174 | 0.016 | |
| positive regulation of skeletal muscle tissue regeneration | GO:0043415 | 4 | 0.016 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.016 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.015 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.015 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.015 | |
| urea transport | GO:0015840 | 4 | 0.015 | |
| cell cell junction organization | GO:0045216 | 72 | 0.015 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.015 | |
| fc receptor mediated inhibitory signaling pathway | GO:0002774 | 1 | 0.015 | |
| sa node cell action potential | GO:0086015 | 4 | 0.015 | |
| foramen ovale closure | GO:0035922 | 1 | 0.015 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.015 | |
| cervix development | GO:0060067 | 2 | 0.015 | |
| sodium ion transport | GO:0006814 | 73 | 0.015 | |
| digestive tract development | GO:0048565 | 190 | 0.015 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.015 | |
| regulation of cell shape | GO:0008360 | 39 | 0.015 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.015 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.015 | |
| muscle adaptation | GO:0043500 | 39 | 0.015 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.015 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.015 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.015 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.015 | |
| negative regulation of t cell apoptotic process | GO:0070233 | 18 | 0.014 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.014 | |
| actin filament based movement | GO:0030048 | 23 | 0.014 | |
| angiogenesis | GO:0001525 | 201 | 0.014 | |
| myotube cell development | GO:0014904 | 60 | 0.014 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.014 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.014 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.014 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.014 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.014 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.014 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.014 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.014 | |
| linoleic acid metabolic process | GO:0043651 | 6 | 0.014 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.014 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.014 | |
| negative regulation of keratinocyte differentiation | GO:0045617 | 4 | 0.014 | |
| protein oligomerization | GO:0051259 | 67 | 0.014 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.014 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.014 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.014 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.014 | |
| blood circulation | GO:0008015 | 195 | 0.014 | |
| detection of mechanical stimulus involved in sensory perception of sound | GO:0050910 | 16 | 0.014 | |
| coagulation | GO:0050817 | 78 | 0.014 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.014 | |
| iron coordination entity transport | GO:1901678 | 5 | 0.014 | |
| positive regulation of translation | GO:0045727 | 19 | 0.014 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.014 | |
| regulation of cell motility | GO:2000145 | 236 | 0.014 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.014 | |
| protein catabolic process | GO:0030163 | 221 | 0.014 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.014 | |
| positive regulation of sodium ion transmembrane transport | GO:1902307 | 4 | 0.014 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.014 | |
| response to growth factor | GO:0070848 | 198 | 0.013 | |
| response to purine containing compound | GO:0014074 | 28 | 0.013 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.013 | |
| endomembrane system organization | GO:0010256 | 147 | 0.013 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.013 | |
| acetate ester transport | GO:1901374 | 2 | 0.013 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.013 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.013 | |
| lipid transport | GO:0006869 | 98 | 0.013 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.013 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.013 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.013 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.013 | |
| mitochondrion organization | GO:0007005 | 134 | 0.013 | |
| odontogenesis | GO:0042476 | 78 | 0.013 | |
| renal water homeostasis | GO:0003091 | 7 | 0.013 | |
| regulation of thyroid hormone generation | GO:2000609 | 4 | 0.013 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.013 | |
| regulation of anagen | GO:0051884 | 1 | 0.013 | |
| positive regulation of growth | GO:0045927 | 104 | 0.013 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.013 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.013 | |
| milk ejection | GO:0060156 | 1 | 0.013 | |
| positive regulation of steroid hormone secretion | GO:2000833 | 2 | 0.013 | |
| blood coagulation | GO:0007596 | 76 | 0.013 | |
| protein autoprocessing | GO:0016540 | 2 | 0.013 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.012 | |
| circulatory system process | GO:0003013 | 197 | 0.012 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.012 | |
| positive regulation of estrogen secretion | GO:2000863 | 1 | 0.012 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.012 | |
| zymogen activation | GO:0031638 | 41 | 0.012 | |
| embryonic nail plate morphogenesis | GO:0035880 | 3 | 0.012 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.012 | |
| negative regulation of b cell differentiation | GO:0045578 | 4 | 0.012 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.012 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.012 | |
| endocytosis | GO:0006897 | 168 | 0.012 | |
| pigmentation | GO:0043473 | 71 | 0.012 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.012 | |
| t cell proliferation | GO:0042098 | 120 | 0.012 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.012 | |
| spermatid development | GO:0007286 | 108 | 0.012 | |
| protein ubiquitination | GO:0016567 | 171 | 0.012 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.012 | |
| regulation of cell activation | GO:0050865 | 289 | 0.012 | |
| organelle fission | GO:0048285 | 170 | 0.012 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.012 | |
| neural retina development | GO:0003407 | 41 | 0.012 | |
| platelet activation | GO:0030168 | 40 | 0.012 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.012 | |
| regulation of coagulation | GO:0050818 | 31 | 0.012 | |
| oviduct development | GO:0060066 | 3 | 0.012 | |
| leukotriene production involved in inflammatory response | GO:0002540 | 2 | 0.012 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.012 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 30 | 0.012 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.012 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.012 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.012 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.012 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.012 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.012 | |
| regulation of systemic arterial blood pressure by atrial natriuretic peptide | GO:0003050 | 2 | 0.011 | |
| epithelial cell migration | GO:0010631 | 63 | 0.011 | |
| tyrosine metabolic process | GO:0006570 | 4 | 0.011 | |
| negative regulation of meiotic cell cycle phase transition | GO:1901994 | 3 | 0.011 | |
| lung induction | GO:0060492 | 3 | 0.011 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.011 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.011 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.011 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.011 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.011 | |
| cell junction assembly | GO:0034329 | 52 | 0.011 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.011 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.011 | |
